Brief: Meiji Holdings - Notice Concerning Submission Of Clinical Trial Notification For Pediatric Phase Iii Of Kd-414, A Covid-19 Vaccine Effective Against Mutant Strains
16/10/2023 07:03
Oct 16 (Reuters) - Meiji Holdings Co Ltd 2269.T :
* MEIJI HOLDINGS - NOTICE CONCERNING SUBMISSION OF CLINICAL
TRIAL
NOTIFICATION FOR PEDIATRIC PHASE III OF KD-414, A COVID-19
VACCINE EFFECTIVE AGAINST MUTANT STRAINS
Source text for Eikon: ID:nTSvp8a45a
Further company coverage: 2269.T
(Reporting by Satoshi Sugiyama)
((Satoshi.Sugiyama@thomsonreuters.com;))